Daniel Vapnek
Corporate Officer/Principal bei University of California, Santa Barbara
Profil
Dr. Daniel Vapnek is an Advisor at Iguana Healthcare Management LLC.
He was Senior Vice president for Research at Amgen from 1981-1997.
During his tenure, scientists under his direction developed Epogen and Neupogen and discovered the RANK ligand which laid the groundwork for the development of denosumab for the treatment of osteoporosis.
For the past decade, Dr. Vapnek has been an advisor to venture capital funds and involved in several startups including BioArray solutions, which was recently sold to Immucor.
He is currently on The Board of Directors of Medicinova and an Adjunct Professor of Cellular and Molecular Biology at the University of California Santa Barbara.
Prior to joining Amgen, he was Professor of Molecular and Population Biology at the University of Georgia.
Dr. Vapnek received his undergraduate degree from the University of Miami (Florida) and a doctorate degree from the University of Miami (Florida).
Aktive Positionen von Daniel Vapnek
| Unternehmen | Position | Beginn |
|---|---|---|
| University of California, Santa Barbara | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Daniel Vapnek
| Unternehmen | Position | Ende |
|---|---|---|
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Direktor/Vorstandsmitglied | 01.04.2007 |
| Protein Pathways, Inc. | Vorsitzender | 01.11.2004 |
| ASPIRA WOMEN'S HEALTH INC. | Direktor/Vorstandsmitglied | 01.05.2001 |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.1996 |
| University of Georgia | Corporate Officer/Principal | - |
Ausbildung von Daniel Vapnek
| University of Miami | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| MEDICINOVA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
BioArray Solutions Ltd.
 BioArray Solutions Ltd. Pharmaceuticals: OtherHealth Technology BioArray Solutions Ltd. develops and manufactures products for transfusion and transplantation medicine. Its solutions proprietary technology platform combines semiconductor technology, micro particle chemistry, and molecular biology to bring unparalleled flexibility and performance to quantitative DNA and protein analysis. The company was founded in 1997 and is headquartered in Warren, NJ. | Health Technology |
| Protein Pathways, Inc. |
